Global Sexually Transmitted Disease (STD) Testing (Test Services, Diagnostics) Markets Report 2019: Focus on Chlamydia, Gonorrhea, Syphilis, HPV, HIV, HSV, TV

News provided by

Jul 26, 2019, 11:00 ET

DUBLIN, July 26, 2019 /PRNewswire/ -- The "Sexually Transmitted Disease (STD) Testing Markets (Test Services, Diagnostics)" report has been added to ResearchAndMarkets.com's offering.

Sexually transmitted diseases (STDs) are a major public health issue. There occur approximately 550 million new STDs annually worldwide. In the US, there are more than 35 million each year. Sexually Transmitted Disease (STD) Testing Markets (Test Services, Diagnostics) analyzes the current and potential world market from 2018 to 2023 for tests and systems used to diagnose STDs.
The key STDs and diagnostics covered in the report are the following:

Chlamydia
Gonorrhea
Syphilis
Human Papillomavirus (HPV)
Human immunodeficiency viruses (HIV)
Herpes simplex virus (HSV)
Trichomonas vaginalis (TV)

Geographic Analysis

STD government initiatives worldwide along with advances in healthcare infrastructure are projected to provide a basis for STD market growth. The market for STD diagnostic systems and tests is being driven by efforts worldwide that aim to screen, diagnose, and treat STD infections. To improve the STD landscape, healthcare systems globally have initiated national screening and also incentivized voluntary screening.

Market Analysis by Disease and Region

Sexually Transmitted Disease (STD) Testing Markets examines the diagnostics market for different STDs based on key individual country and regional markets. An increasing number of cases necessitate more complete reporting in developed as well as developing economies. Potential market opportunities lie in improved screening and better awareness, although the stigma of the infection may make people hesitant to be tested and may slightly impede the market growth.

Market Analysis by Testing Location and by Laboratory Type

Laboratory-based testing for STDs currently holds a greater share of the STD diagnostics market. Commercialized POC STD diagnostic technologies are in their early stages and continue to evolve into the marketplace.

Market Analysis by Testing Device

There are several possible STD diagnostic methods in the laboratory, including molecular platforms, lateral flow assays, flow cytometry, and ELISA diagnostics. Lateral flow immunoassays are among the more simple and successful rapid diagnostics, technical advances have resulted in the one-step lateral flow test chemistry often used today. The transition to molecular techniques has optimized the validity of procedures and has sped the time to receiving test results. Flow cytometry - a laboratory technique which measures and analyzes several physical characteristics of cells as they move in a stream under a light beam - should increase thanks to the accuracy of the technology. Technological advancements in ELISA test kits for STD detection are expected to foster growth in this segment as well.

Market Trends and Developments

An examination of developing STD trends can reveal opportunities for manufacturers of STD diagnostic tests and systems. Market issues discussed in the report include:

Incidence, Prevalence, and Cost of STDs
Antibiotic Resistance
Non-Reportable STDs
Emerging STDs
Newborn Syphilis Cases
STDs in Women and Infants
European vs. US Rates
Highly Susceptible Groups
Novel Antibiotics Targets Gonorrhea
At-Home HPV Testing
First Test to Aid in Diagnosis of Mycoplasma genitalium
Funding POC Test Development

Competitive Landscape

The growth in the prevalence of STDs has helped spur the market for STD testing that is benefitting the global STD testing manufacturers.

Sexually Transmitted Disease (STD) Testing Markets (Test Services, Diagnostics) provides profiles of key players in the market, including:

Alere-Abbott
Atlas Genetics Ltd. - Binx Health
Beckman Coulter-Danaher
Becton Dickinson
Biomeme
bioMrieux
Cepheid-Danaher
GenePOC
Hologic
Meridian Bioscience
OraSure Technologies
QIAGEN
QuantuMDx
Quidel
Roche Diagnostics
Seegene
Sekisui Diagnostics
Siemens Healthineers
Trinity Biotech Plc
uBiome

Key Topics Covered:

1. Executive Summary

Overview
Growth in Cases of STDs
Overview of STD Markets
Methodology

2. Introduction

STDs Defined
Economic Impact
Modernizing Surveillance
Key STDs
Chlamydia
Gonorrhea
Syphilis
Human Papillomavirus (HPV)
Trichomonas Vaginalis
Human Immunodeficiency Viruses (HIV)
Herpes Simplex Virus (HSV)

3. Incidence-Prevalence Overview

US
International
STDs in Women and Infants

4. Market Trends and Analysis

Incidence, Prevalence, and Cost of STDs
Antibiotic Resistance
Non-Reportable STDs
Emerging STDs
Newborn Syphilis Cases
STDs in Women and Infants
European vs. US Rates
Highly Susceptible Groups
Table Increased Rates of Syphilis, 2016 to 2017
STD Test Services Issues

5. Market Developments

Novel Antibiotics Targets Gonorrhea
Standard Treatment
New App for Consumers
Test Results in 30 Minutes
At-Home HPV Testing
Siemens Acquisition
First Test to Aid in Diagnosis of Mycoplasma genitalium
Automated RPR Syphilis Analyzer
HSV Test Gets FDA Clearance
FDA Clearance for cobas CT/NG for cobas Systems
Funding POC Test Development
HPV Test Approval

6. Market Data

Overview
Growing Need for Testing
Geographic Analysis
Miniaturization and POC
Market Analysis by Disease and Region
Market Analysis by Testing Location
Market Analysis by Testing Device

7. Competitive Landscape

For more information about this report visit https://www.researchandmarkets.com/r/o8dc2w

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets